Notably, SF3B1 mutations are associated with MDS with ringed sideroblasts (MDS-RS), while SRSF2 mutations are linked to chronic myelomonocytic leukemia (CMML) [25,26]. Here, SF3B1 is linked to chronic myelomonocytic leukemia.